Association of genetic variants with dyslipidemia

被引:25
|
作者
Abe, Shintaro [1 ]
Tokoro, Fumitaka [1 ]
Matsuoka, Reiko [1 ]
Arai, Masazumi [1 ]
Noda, Toshiyuki [1 ]
Watanabe, Sachiro [1 ]
Horibe, Hideki [2 ]
Fujimaki, Tetsuo [3 ]
Oguri, Mitsutoshi [4 ]
Kato, Kimihiko [5 ]
Minatoguchi, Shinya [6 ]
Yamada, Yoshiji [7 ]
机构
[1] Gifu Prefectural Gen Med Ctr, Dept Cardiol, Gifu, Gifu 5008717, Japan
[2] Gifu Prefectural Tajimi Hosp, Dept Cardiovasc Med, Tajimi, Gifu 5078522, Japan
[3] Inabe Gen Hosp, Dept Cardiovasc Med, Inabe, Mie 5110428, Japan
[4] Japanese Red Cross Nagoya First Hosp, Dept Cardiol, Nagoya, Aichi 4538511, Japan
[5] Meitoh Hosp, Dept Internal Med, Nagoya, Aichi 4650025, Japan
[6] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Gifu 5011194, Japan
[7] Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, Tsu, Mie 5148507, Japan
关键词
dyslipidemia; hypertriglyceridemia; hypo-high density lipoprotein-cholesterolemia; genetics; polymorphism; hyper-low density lipoprotein-cholesterolemia; INTERLEUKIN-6 RECEPTOR GENE; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; LIPID-LEVELS; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN A5; PLASMA-LIPIDS; HEART-DISEASE; LOCI; POLYMORPHISM;
D O I
10.3892/mmr.2015.4081
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although genetic variants, which regulate lipid metabolism, have been extensively investigated in Caucasian populations, the genes, which confer susceptibility to dyslipidemia in Japanese individuals, remain to be elucidated. The aim of the present study was to examine a possible association among hypertriglyceridemia, hypo-high density lipoprotein (HDL)-cholesterolemia or hyper-low density lipoprotein (LDL)-cholesterolemia in Japanese individuals with 29 polymorphisms observed to confer susceptibility for coronary heart disease. This was performed through meta-analyses of genome-wide association studies in Caucasian populations. The study population comprised 2,354 individuals with dyslipidemia (hypertriglyceridemia, hypo-HDL-cholesterolemia or hyper-LDL-cholesterolemia) and 3,106 control individuals. To compensate for multiple comparisons of genotypes, a false discovery rate (FDR) of <0.05 was adopted to determine the statistical significance of the associations. Comparisons of allele frequencies using the 7(2 test revealed that rs964184 of zinc finger gene (ZPR1; FDR=2.1x10(-7)), rs4845625 of interleukin 6 receptor (IL6R; FDR=0.032), rs46522 of ubiquitin-conjugating enzyme E2Z gene (UBE2Z; FDR=0.032) and rs17514846 of furin (FDR=0.041) were significantly associated with hypertriglyceridemia. The X-2 test revealed that rs599839 of proline/serine-rich coiled-coil 1 (PSRC1; FDR=0.004) and rs2075650 of translocase of outer mitochondrial membrane 40 homolog (TOMM40; FDR=0.004) were significantly associated with hyper-LDL-cholesterolemia. Multivariate logistic regression analysis with adjustment for age, gender and body mass index revealed that rs964184 of ZPR1 (P=5.1x10(-7); odds ratio, 1.37; dominant model), rs4845625 of IL6R (P=0.0019, odds ratio, 1.25; dominant model) and rs46522 of UBE2Z (P=0.0039, odds ratio, 1.19; dominant model) were significantly associated with hypertriglyceridemia, and that rs599839 of PSRC1 (P=0.0004, odds ratio, 0.70; dominant model) and rs2075650 of TOMM40 (P=0.0004, odds ratio, 1.43; dominant model) were significantly associated with hyper-LDL-cholesterolemia. Therefore, ZPR1, IL6R, and UBE2Z may be susceptibility loci for hypertriglyceridemia, whereas PSRC1 and TOMM40 may be such loci for hyper-LDL-cholesterolemia in Japanese individuals.
引用
收藏
页码:5429 / 5436
页数:8
相关论文
共 50 条
  • [1] Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study
    Yamada, Yoshiji
    Matsui, Kota
    Takeuchi, Ichiro
    Fujimaki, Tetsuo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (05) : 1290 - 1300
  • [2] Prediction of genetic risk for dyslipidemia
    Yamada, Yoshiji
    Matsuo, Hitoshi
    Warita, Shunichiro
    Watanabe, Sachiro
    Kato, Kimihiko
    Oguri, Mitsutoshi
    Yokoi, Kiyoshi
    Metoki, Norifumi
    Yoshida, Hidemi
    Satoh, Kei
    Ichihara, Sahoko
    Aoyagi, Yukitoshi
    Yasunaga, Akitomo
    Park, Hyuntae
    Tanaka, Masashi
    Nozawa, Yoshinori
    GENOMICS, 2007, 90 (05) : 551 - 558
  • [3] Genetic variants influencing lipid levels and risk of dyslipidemia in Chinese population
    Luo, Huaichao
    Zhang, Xueping
    Shuai, Ping
    Miao, Yuanying
    Ye, Zimeng
    Lin, Ying
    JOURNAL OF GENETICS, 2017, 96 (06) : 985 - 992
  • [4] Association of six genetic variants with myocardial infarction
    Matsuoka, Reiko
    Abe, Shintaro
    Tokoro, Fumitaka
    Arai, Masazumi
    Noda, Toshiyuki
    Watanabe, Sachiro
    Horibe, Hideki
    Fujimaki, Tetsuo
    Oguri, Mitsutoshi
    Kato, Kimihiko
    Minatoguchi, Shinya
    Yamada, Yoshiji
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (05) : 1451 - 1459
  • [5] Association of genetic variants with myocardial infarction in Japanese individuals with or without metabolic syndrome
    Kawamiya, Toshiki
    Kato, Kimihiko
    Horibe, Hideki
    Yokoi, Kiyoshi
    Oguri, Mitsutoshi
    Yoshida, Tetsuro
    Fujimaki, Tetsuo
    Watanabe, Sachiro
    Satoh, Kei
    Aoyagi, Yukitoshi
    Nozawa, Yoshinori
    Murohara, Toyoaki
    Yamada, Yoshiji
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (06) : 969 - 975
  • [6] Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study
    Yamada, Yoshiji
    Matsui, Kota
    Takeuchi, Ichiro
    Oguri, Mitsutoshi
    Fujimaki, Tetsuo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (05) : 1189 - 1198
  • [7] Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
    Rodrigues, A. C.
    Sobrino, B.
    Genvigir, F. D. V.
    Willrich, M. A. V.
    Arazi, S. S.
    Dorea, E. L.
    Bernik, M. M. S.
    Bertolami, M.
    Faludi, A. A.
    Brion, M. J.
    Carracedo, A.
    Hirata, M. H.
    Hirata, R. D. C.
    CLINICA CHIMICA ACTA, 2013, 417 : 8 - 11
  • [8] Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome
    Hiramatsu, Mizuho
    Oguri, Mitsutoshi
    Kato, Kimihiko
    Horibe, Hideki
    Fujimaki, Tetsuo
    Watanabe, Sachiro
    Satoh, Kei
    Aoyagi, Yukitoshi
    Tanaka, Masashi
    Shin, Dong-Jik
    Lee, Jong Ho
    Jang, Yangsoo
    Yamada, Yoshiji
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 (01) : 185 - 192
  • [9] Identification of eight genetic variants as novel determinants of dyslipidemia in Japanese by exome-wide association studies
    Yamada, Yoshiji
    Sakuma, Jun
    Takeuchi, Ichiro
    Yasukochi, Yoshiki
    Kato, Kimihiko
    Oguri, Mitsutoshi
    Fujimaki, Tetsuo
    Horibe, Hideki
    Muramatsu, Masaaki
    Sawabe, Motoji
    Fujiwara, Yoshinori
    Taniguchi, Yu
    Obuchi, Shuichi
    Kawai, Hisashi
    Shinkai, Shoji
    Mori, Seijiro
    Arai, Tomio
    Tanaka, Masashi
    ONCOTARGET, 2017, 8 (24) : 38950 - 38961
  • [10] Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients
    Abd El-Fattah, Amal Ahmed
    Sadik, Nermin Abdel Hamid
    Sedrak, Heba
    Battah, Ahmed
    Nabil, Mai
    GENE, 2018, 641 : 212 - 219